로딩 중…
지수 로딩 중…
Abpro Bio Co., Ltd.
195990· KOSDAQ· Industrials· Capital Goods
₩1,011-1.37%
2026-11-02
Financials
Valuation Metrics
Abpro Bio Co., Ltd.'s Market Cap is ₩165B. At end of 2025 it was ₩725B. Ranked #2345 of 2,405 in KR market (top 98%), #1578 of 1,627 on KOSDAQ (top 97%), #351 of 361 in Capital Goods (top 97%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 16.47B KRW | KR#2,345/2,405 Sec#351/361 |
| Revenue | 30.84B KRW | KR#2,015/2,405 Sec#317/361 |
| Net Income | -5.06B KRW | KR—/2,405 Sec—/361 |
| Total Assets | 75.72B KRW | KR#1,959/2,405 Sec#317/361 |
| Net Assets | 51.79B KRW | KR#1,882/2,405 Sec#306/361 |
| Employees | 46 | KR#2,075/2,405 Sec#319/361 |
| Value | ||
| P/B | 0.32x | KR#443/2,405 Sec#63/361 |
| P/S | 0.53x | KR#1,023/2,405 Sec#146/361 |
| FCF Yield | -52.23% | KR—/2,405 Sec—/361 |
| Profitability | ||
| ROE | -9.77% | KR#1,928/2,405 Sec#290/361 |
| ROA | -6.68% | KR#1,997/2,405 Sec#301/361 |
| Op. Margin | -31.99% | KR#2,169/2,405 Sec#327/361 |
| Revenue Growth | -25.85% | KR#2,175/2,405 Sec#304/361 |
| Financial Health | ||
| Debt Ratio | 46.20% | KR#902/2,405 Sec#109/361 |
| Total Debt | 17.69B KRW | KR#1,416/2,405 Sec#244/361 |
| FCF | -8.60B KRW | KR#1,656/2,405 Sec#240/361 |
| Cash | 10.81B KRW | KR#1,650/2,405 Sec#269/361 |
| Current Ratio | 2.71x | KR#625/2,405 Sec#64/361 |
| Performance | ||
| 1Y Return | -67.90% | KR#2,244/2,405 Sec#339/361 |
| 1M Return | -10.45% | KR#1,199/2,405 Sec#128/361 |
| From 52W High | -86.79% | KR#2,373/2,405 Sec#356/361 |
| 1Y MDD | -85.53% | KR#2,351/2,405 Sec#354/361 |
| Trading | ||
| Volume | 23,683 shares | KR#1,395/2,405 Sec#247/361 |
| Trading Value | 23.5M KRW | KR#2,036/2,405 Sec#325/361 |
| Foreign Own. | 0.00% | KR—/2,405 Sec—/361 |
| Per Share | ||
| EPS | -311 KRW | KR—/2,405 Sec—/361 |
| BPS | 3,180 KRW | KR#1,829/2,405 Sec#289/361 |
Company Info
동사는 2004년 공작기계 생산·판매 목적으로 설립되어 2015년 코스닥 상장함. 공작기계는 소형머시닝센터 전문으로 IT·자동차부품 산업을 주력으로 하고, 바이오 부문은 ABP-100과 ABP-201 이중항체의 아시아·중동 48개국 판권을 보유하고 있음. 반도체 장비는 디스플레이·반도체·이차전지 Module 공정 설비 개발 및 공급하고 있으며, 동사는 IT 자동화 설비와 이차전지 Module 핵심 설비 개발 중임. 에이비프로바이오는 2004년에 설립되었으며 대구광역시 달성군에 본사를 두고 있습니다.